Zargis Conducts Physician Study to Show Potential Benefits to Physicians, Insurance Companies and Patients
30 June 2005 - 11:53PM
PR Newswire (US)
Zargis Conducts Physician Study to Show Potential Benefits to
Physicians, Insurance Companies and Patients PRINCETON, N.J., June
30 /PRNewswire/ -- Zargis Medical Corp., a spin-off from Siemens
Corporate Research, and a majority-owned subsidiary of Speedus
Corp. (NASDAQ:SPDE), today announced that it conducted a study in
participation with Johns Hopkins University's School of Medicine to
assess the impact of the Zargis Acoustic Cardioscan(TM) (ZAC(TM))
system on referral decisions made by primary care physicians
regarding heart murmurs -- which are potential signs of heart
disease. In addition, the study was designed to assess ZAC's
ability to support physicians in the detection of murmurs. This
study was based on the analysis, by a group of primary care
physicians, of a series of heart sound recordings obtained from
anonymous subjects who were referred to Johns Hopkins Hospital for
a cardiology consult. The results of the study are expected to be
available later this year. About Zargis Medical Corp. Zargis
Medical Corp. develops advanced diagnostic decision support
products and services for primary care physicians, pediatricians,
cardiologists and other healthcare professionals. Zargis was formed
in 2001 when Siemens Corporate Research, a division of Siemens AG
(NYSE:SI), and Speedus Corp. co-invested to develop and market an
advanced acoustic technology designed to detect heart abnormalities
identified through analysis of heart sounds. About ZAC Zargis has
developed ZAC, the first and only FDA-authorized computer- assisted
medical device to support physicians in analyzing heart sounds for
the identification of suspected murmurs. The non-invasive device is
easy to use, portable, and takes just minutes to perform. ZAC
implements voice-guided protocol and a graphical user interface
while maintaining an efficient physician workflow. The system
provides a summary of findings in terms that are readily understood
by physicians and offers an additional range of quantitative
auscultatory information that cannot be obtained through listening
alone. As a result, ZAC enhances auscultation -- a procedure that
has been universally employed through a stethoscope for nearly two
hundred years. About Speedus Corp. Speedus Corp. is a holding
company with controlling interests in Zargis Medical Corp. and
F&B Gudtfood Holdings, Inc. Speedus Corp. also owns broadband
intellectual property and controls licensed wireless frequencies.
For additional information about Zargis Medical, Speedus Corp. or
the ZAC product, contact Peter Hodge at 888.773.3669 (ext. 23) or ,
or visit the following Web sites: http://www.zargis.com/ and
http://www.speedus.com/. Statements contained herein that are not
historical facts, including but not limited to statements about the
Company's product, corporate identity and focus, may be
forward-looking statements that are subject to a variety of risks
and uncertainties. There are a number of important factors that
could cause actual results to differ materially from those
expressed in any forward- looking statements made by the Company,
including, but not limited to, the continuing development of the
Company's sales, marketing and support efforts. DATASOURCE: Zargis
Medical Corp. CONTACT: Peter Hodge, 1-888-773-3669, ext. 23, , for
Zargis Medical Corp. Web site: http://www.zargis.com/
http://www.speedus.com/
Copyright
Speedus (CE) (USOTC:SPDE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Speedus (CE) (USOTC:SPDE)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Speedus Corp (CE) (OTCMarkets): 0 recent articles
More Speedus (MM) News Articles